Tag Archives: Elecsys AD CSF assays

Roche Diagnostics: Globally, up to 75 percent of people living with Alzheimer’s disease have not been diagnosed

The company announces FDA clearance for its Alzheimer’s disease Cerebrospinal Fluid (CSF) assays The Elecsys® Alzheimer’s disease (AD) CSF assays will be available on the cobas fully automated immunoassay analyzers, enabling patients to get broad access to high quality testing in a timely … Read the full press release